SCHEMBL869115

SCHEMBL869115

C1CCCCCC(COCC2CCCCCCCCCCC2)CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSK P43235 1/20 0.41
LMNA P02545 1/20 0.41
CHRM5 P08912 2/20 0.38
SLC1A3 P43003 2/20 0.38
SLC1A2 P43004 2/20 0.38
SLC1A1 P43005 2/20 0.38
CYP1A2 P05177 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM1 P11229 1/20 0.38
SPHK2 Q9NRA0 4/20 0.37
SPHK1 Q9NYA1 4/20 0.37
GBA1 P04062 1/20 0.36
UGCG Q16739 1/20 0.36
GBA2 Q9HCG7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23039739 1.00 CTSL (0.41) CTSLCTSBCTSKLMNACHRM5
SCHEMBL379081 1.00 CTSL (0.41) CTSLCTSBCTSKLMNACHRM5
SCHEMBL16239892 1.00 CTSL (0.41) CTSLCTSBCTSKLMNACHRM5
SCHEMBL29101108 1.00 CTSL (0.41) CTSLCTSBCTSKLMNACHRM5
SCHEMBL20531 0.97 CTSL (0.38) CTSLCTSBCTSKLMNACHRM5
SCHEMBL29142423 0.93 CTSL (0.37) CTSLCTSBCTSKLMNACHRM5
Hydrochloric Acid SCHEMBL14346462 0.93 CTSL (0.37) CTSLCTSBCTSKLMNASLC1A3
Methyl Alcohol SCHEMBL16210946 0.91 LMNA (0.42) CTSLCTSBCTSKLMNASLC1A3
Methyl Alcohol SCHEMBL17513807 0.91 LMNA (0.42) CTSLCTSBCTSKLMNASLC1A3
Hydroxyamine SCHEMBL9050574 0.91 SLC1A3 (0.42) CTSLCTSBCTSKLMNASLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2662434-B2 Use of specific compounds for enhancing odours SYMRISE AG (DE) 2023-08-16 EP claimed
EP-3601509-A1 FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER Symrise AG (DE) 2020-02-05 EP claimed
EP-2662098-B1 Use of specific compounds for changing odours SYMRISE AG (DE) 2018-10-24 EP claimed
WO-2018171872-A1 FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER SYMRISE AG (DE) 2018-09-27 WO claimed
EP-2662434-B1 Use of specific compounds for enhancing odours SYMRISE AG (DE) 2018-03-21 EP claimed
EP-2174645-B1 Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate SYMRISE AG (DE) 2015-07-29 EP claimed
US-8999913-B2 Fragrance mixtures containing cyclopent-2-enyl ethyl acetate SYMRISE AG (DE) 2015-04-07 US claimed
EP-2662098-A1 Use of specific compounds for changing odours Symrise AG (DE) 2013-11-13 EP claimed
EP-2662434-A1 Use of specific compounds for enhancing odours Symrise AG (DE) 2013-11-13 EP claimed
US-20130172429-A1 FRAGRANCE MIXTURES CONTAINING CYCLOPENT-2-ENYL ETHYL ACETATE SYMRISE AG (DE) 2013-07-04 US claimed
EP-2474301-A1 Perfume mixtures containing Cyclopent-2-Enyl-ethyl acetate Symrise AG (DE) 2012-07-11 EP claimed
EP-2174645-A2 Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate Symrise GmbH & Co. KG (DE) 2010-04-14 EP claimed
EP-2158896-A2 Materials containing aromas incorporating neopentyl glycol isononanoate Symrise GmbH & Co. KG (DE) 2010-03-03 EP claimed
EP-4724434-A1 AMBERGRIS ISOMERS AND MIXTURES THEREOF Symrise AG (DE) 2026-04-15 EP disclosed
EP-3826986-B1 NOVEL ODORANTS HAVING ROSE ODOUR SYMRISE AG (DE) 2026-03-04 EP disclosed
US-12545851-B2 Fragrances with note of lily of the valley SYMRISE AG (DE) 2026-02-10 US disclosed
EP-1111029-A2 Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one HAARMANN & REIMER GMBH (DE) 2001-06-27 EP disclosed
WO-2001038440-A1 WAX FORMULATIONS CONTAINING ODORIFEROUS SUBSTANCES HAARMANN & REIMER GMBH (DE) 2001-05-31 WO disclosed
WO-2001023373-A2 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE HAARMANN & REIMER GMBH (DE) 2001-04-05 WO disclosed
EP-1067126-A2 Tetracyclic acetals HAARMANN & REIMER GMBH (DE) 2001-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545851-B2 Fragrances with note of lily of the valley TRPA1, CDY1; CDY1B, TMEM109 CTSL 4684/4885CTSB 4349/4885CTSK 4032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.